FindTrial
Sign In

Effects of Community Pharamcists' Medication Assisst for the Patients Taking Antihypertensives

Effects of Community Pharamcists' Medication Assisst for the Patients Taking Antihypertensives - Effects of Community Pharamcists' Medication Assisst for the Patients Taking Antihypertensives

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000037954
Enrollment
60
Registered
2019-09-10
Start date
2019-06-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Medication support based on cognitive behavioral therapy Medication consultation by phone

Sponsors

Osaka University of Pharmaceutical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with depression

Exclusion criteria

Exclusion criteria: Dementia, bipolar, schizophrenia, patients who have difficulty in answering questionnaires

Design outcomes

Primary

MeasureTime frame
Medication Adherence during the intervention period (6 months)—

Secondary

MeasureTime frame
QOL, Cost-effectiveness, Severity of the disease, The relationship between pharmacists and patients—

Countries

Japan

Contacts

Public ContactMasaki Shoji

Osaka University of Pharmaceutical Sciences laboratory of Social and Administrative Pharmacy

shoji@gly.oups.ac.jp072-690-1059

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026